PAN HONG HOLDINGS GROUP LIMITED (P36)
General Announcement: RESPONSES TO QUESTIONS FROM SIAS ON THE COMPANYS ANNUAL REPORT FOR FYE 31 MARCH 2026
General Announcement: RESPONSES TO QUESTIONS FROM SIAS ON THE COMPANYS ANNUAL REPORT FOR FYE 31 MARCH 2026
KOIL Energy Announces Successful Commissioning of New Mobile Barge Carousel
Seanergy Maritime Reports Second Quarter and First-Half 2026 Financial Results
Dorian LPG Ltd. Announces First Quarter 2027 Earnings and Conference Call Date and Completion of the Sale of Constellation
Share Buy Back - Daily Share Buy-Back Notice: Share Buy Back - Daily Share Buy-Back Notice
General Announcement: Current Report on Form 8-K Filing - CEO Letter
Annual General Meeting :
Lucid Diagnostics to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 13, 2026
Perrigo Announces Quarterly Dividend
Johnson & Johnson - Johnson & Johnsons RYBREVANTFASPRO™ (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Priority Review as potential first-in-class EGFR- and MET-targeted subcutaneous treatment for advanced head and neck cancer